Chemicals News and Research

RSS

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

Springer and the American College of Medical Toxicology (ACMT) have signed an agreement to collaborate on the publication of the Journal of Medical Toxicology (JMT), the official journal of the ACMT, beginning in March 2010. It was previously published by the University of Pennsylvania Press.

25 Nov 2009

Alzheimer's disease research leads to more effective UTI treatments

Research into Alzheimer's disease seems an unlikely approach to yield a better way to fight urinary tract infections (UTIs), but that's what scientists at Washington University School of Medicine in St. Louis and elsewhere recently reported.

24 Nov 2009

New finding reveals Barrett's esophagus in asymptomatic women undergoing endoscopic screening

In the November issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE), a study out of Stanford University found that Barrett's esophagus was detected in six percent of asymptomatic women undergoing endoscopic screening.

24 Nov 2009

ICL announces financial results for third-quarter 2009

ICL, a multinational fertilizer and specialty chemicals company, today reported results for the third quarter and nine months ended September 30, 2009.

24 Nov 2009

Exposure to environmental pollutants is associated with asthma symptoms in children

Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children, according to a new study by researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health.

24 Nov 2009

New FluCide better than the older version

NanoViricides, Inc., announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide™ is superior to the older version.

23 Nov 2009

Chemical-based tooth whitening or bleaching agents may be harmful, ADA warns

The American Dental Association (ADA) today asked the U.S. Food and Drug Administration (FDA) to establish appropriate classifications for tooth-whitening chemicals.

21 Nov 2009

Scientists find how 4-HB is metabolized by the body

It's a naturally occurring brain chemical with an unwieldy name: 4-hydroxybutyrate (4-HB). Taken by mouth, it can be abused or used as a date-rape drug.

20 Nov 2009

GERD is an immune-mediated injury and not the result of acid burn, says new study

Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study.

20 Nov 2009

NIEHS grants $13 million for engineered nanomaterials research

The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is increasing its investment in understanding the potential health, safety and environmental issues related to tiny particles that are used in many everyday products such as sunscreens, cosmetics and electronics. The NIEHS will award about $13 million over a two-year period, through the American Recovery and Reinvestment Act, to bolster the NIEHS's ongoing research portfolio in the area of engineered nanomaterials (ENMs).

20 Nov 2009

WPI researchers develop new model system to study fungal infections

A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections. The system can be a powerful tool for screening potential drug targets for conditions like thrush, athlete's foot and vaginal yeast infections, which affect millions of people each year but are difficult to treat with existing medications. Using the new model, the researchers also identified a gene that may be a promising target for a new anti-fungal drug.

20 Nov 2009

Curemark begins enrolling patients in Phase III clinical trials for CM-AT

Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at three additional clinical trial sites.

20 Nov 2009

New report finds positive association between phthalate exposure and ADHD symptoms

Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Studies to date on phthalates have been inconsistent, with some linking exposure to these chemicals to hormone disruptions, birth defects, asthma, and reproductive problems, while others have found no significant association between exposure and adverse effects.

19 Nov 2009

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows.

19 Nov 2009

The Center for Modeling Optimal Outcomes discovers causal path of autism

During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.

18 Nov 2009

Electronic cigarettes, a viable and much-needed alternative to combustible tobacco

The Electronic Cigarette Association (ECA) today urged decision-makers to seek alternatives to combustible tobacco that reduce Americans’ exposure to the multitude of harmful chemicals and toxins found in cigarettes.

18 Nov 2009

Students from the University of Edinburgh create custom-made bacteria to detect buried explosives

Scientists have developed a simple, cheap, accurate test to find undetected landmines.

17 Nov 2009

New insights into cells' reaction to DNA damage

Cancer researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have gained new insights into how cells react to DNA damage. Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit have shown that the protein PARP-1, which detects DNA damage within seconds, activates the transcription factor NF-kappaB, a well-known regulator of gene expression.

17 Nov 2009

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury. The finding has implications for such inflammation-based disorders as cystic fibrosis (CF), diabetes, heart disease, and neurodegeneration.

17 Nov 2009

NRC helps Olympus to design and commercialize CARS microscope

The National Research Council Canada (NRC) recently helped Olympus, a world leader in advanced optical microscopy and medical imaging, to design and commercialize a CARS (Coherent Anti-stokes Raman Scattering) microscope.

From Evident Corporation - Life Sciences 16 Nov 2009

Chemicals News and Research

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

Alzheimer's disease research leads to more effective UTI treatments

New finding reveals Barrett's esophagus in asymptomatic women undergoing endoscopic screening

ICL announces financial results for third-quarter 2009

Exposure to environmental pollutants is associated with asthma symptoms in children

New FluCide better than the older version

Chemical-based tooth whitening or bleaching agents may be harmful, ADA warns

Scientists find how 4-HB is metabolized by the body

GERD is an immune-mediated injury and not the result of acid burn, says new study

NIEHS grants $13 million for engineered nanomaterials research

WPI researchers develop new model system to study fungal infections

Curemark begins enrolling patients in Phase III clinical trials for CM-AT

New report finds positive association between phthalate exposure and ADHD symptoms

Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup

The Center for Modeling Optimal Outcomes discovers causal path of autism

Electronic cigarettes, a viable and much-needed alternative to combustible tobacco

Students from the University of Edinburgh create custom-made bacteria to detect buried explosives

New insights into cells' reaction to DNA damage

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

NRC helps Olympus to design and commercialize CARS microscope

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery